Regulus Therapeutics, Inc. Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development

CARLSBAD, Calif.--(BUSINESS WIRE)--Regulus Therapeutics Inc., a company developing microRNA therapeutics, today announced the appointment of Zachary A. Zimmerman, Ph.D., as director of business development. Dr. Zimmerman will be responsible for business development and licensing, as well as managing external collaborations and communications.
MORE ON THIS TOPIC